Osteoporosis Drugs Market to Witness Robust Expansion by 2028

The osteoporosis drugs market is expected to reach $10,479 million by 2028, registering a CAGR of 4% from 2022 to 2028. Osteoporosis is defined as a medical condition characterized by low bone density and quality in humans. In addition, the bones become porous in this medical condition, which makes them more fragile and, in turn, prone to fractures. The condition is caused by an overproduction of the hormone called parathyroid. The condition can lead to serious fractures, which can have deleterious effects on the patient’s health. Therefore, the disease requires treatment, which includes the use of drugs against osteoporosis. Some of the drugs available on the market include selective estrogen receptor modulator bisphosphonate (SERM), parathyroid hormone therapy, calcitonin and RANK ligand inhibitors. These drugs are administered through different routes in the body, orally or intravenously.

Company Profile

• Amgen Inc.
• Hoffmann-La Roche AG
• Radius Health
• Merck & Co. Inc.
• Novartis International AG (Sandoz)
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited

Market Segmentation

By Drug Class

• Bisphosphonates
• Selective Estrogen Inhibitors Modulator (SERM)
• Parathyroid Hormone Therapy
• Calcitonin
• Rank Ligand Inhibitors

By Route of Administration

• Oral
• Injectable

Scope of the Report

The research study analyzes the Osteoporosis Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Osteoporosis Drugs Market Report

1. What was the Osteoporosis Drugs Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Osteoporosis Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Osteoporosis Drugs Market was the market leader in 2021?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Key Benefits of Buying the Osteoporosis Drugs Market Report:

• Comprehensive analysis of the changing competitive landscape.
• Assists in decision making processes for the businesses along with detailed strategic planning methodologies.
• The report offers an 8-year forecast and assessment of the Osteoporosis Drugs
• Helps in understanding the key product segments and their estimated growth rate.
• In-depth analysis of market drivers, restraints, trends, and opportunities.
• Comprehensive regional analysis of the Osteoporosis Drugs
• Extensive profiling of the key stakeholders of the business sphere.
• Detailed analysis of the factors influencing the growth of the Osteoporosis Drugs Market.